MX366639B - Derivado de bifenilo novedoso y metodo para preparar el mismo. - Google Patents
Derivado de bifenilo novedoso y metodo para preparar el mismo.Info
- Publication number
- MX366639B MX366639B MX2016001200A MX2016001200A MX366639B MX 366639 B MX366639 B MX 366639B MX 2016001200 A MX2016001200 A MX 2016001200A MX 2016001200 A MX2016001200 A MX 2016001200A MX 366639 B MX366639 B MX 366639B
- Authority
- MX
- Mexico
- Prior art keywords
- biphenyl derivative
- disease
- novel biphenyl
- isomer
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020130090175A KR101538846B1 (ko) | 2013-07-30 | 2013-07-30 | 신규한 바이페닐 유도체 및 그의 제조방법 |
| PCT/KR2014/006483 WO2015016511A1 (fr) | 2013-07-30 | 2014-07-17 | Nouveau dérivé de biphényle, et son procédé de préparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016001200A MX2016001200A (es) | 2016-08-17 |
| MX366639B true MX366639B (es) | 2019-07-17 |
Family
ID=52431993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016001200A MX366639B (es) | 2013-07-30 | 2014-07-17 | Derivado de bifenilo novedoso y metodo para preparar el mismo. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9828339B2 (fr) |
| EP (1) | EP3029026B1 (fr) |
| JP (1) | JP6109425B2 (fr) |
| KR (1) | KR101538846B1 (fr) |
| CN (1) | CN105555761B (fr) |
| AU (1) | AU2014297144B2 (fr) |
| CA (1) | CA2919624C (fr) |
| ES (1) | ES2710389T3 (fr) |
| IL (1) | IL243830B (fr) |
| MX (1) | MX366639B (fr) |
| MY (1) | MY175411A (fr) |
| PH (1) | PH12016500197B1 (fr) |
| PT (1) | PT3029026T (fr) |
| RU (1) | RU2644234C2 (fr) |
| SG (1) | SG11201600624RA (fr) |
| TR (1) | TR201901449T4 (fr) |
| UA (1) | UA116480C2 (fr) |
| WO (1) | WO2015016511A1 (fr) |
| ZA (1) | ZA201601227B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102239776B1 (ko) | 2016-08-26 | 2021-04-13 | 동아에스티 주식회사 | (r)-(1-메틸피롤리딘-3-일)메틸(3'-클로로-4'-플루오로-[1,1'-비페닐]-2-일)카바메이트의 신규염 및 이의 결정형 |
| MY200068A (en) * | 2016-08-26 | 2023-12-06 | Dong A St Co Ltd | Novel salt of (r)-(1-methylpyrrolidine-3-yl)methyl(3'-chloro-4'-fluoro-[1,1'-biphenyl]-2-yl)carbamate and a crystal form thereof |
| KR102611847B1 (ko) * | 2023-03-27 | 2023-12-12 | 주식회사 이플라스크 | 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1140447A (zh) * | 1994-02-10 | 1997-01-15 | 山之内制药株式会社 | 新的氨基甲酸酯衍生物及其药物组合物 |
| WO1995021820A1 (fr) * | 1994-02-10 | 1995-08-17 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive du carbamate et composition correspondante |
| US5613402A (en) * | 1995-06-06 | 1997-03-25 | Itt Automotive, Inc. | Adjustable set bearing |
| AU783095B2 (en) | 1999-12-07 | 2005-09-22 | Theravance Biopharma R&D Ip, Llc | Carbamate derivatives having muscarinic receptor antagonist activity |
| TW200534855A (en) | 2004-01-13 | 2005-11-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| EP1781607A2 (fr) | 2004-08-19 | 2007-05-09 | Ranbaxy Laboratories Limited | Derives de pyrrolidine utilises en tant qu'antagonistes des recepteurs muscariniques |
| WO2007007282A2 (fr) * | 2005-07-11 | 2007-01-18 | Ranbaxy Laboratories Limited | Antagonistes des recepteurs muscariniques |
| WO2007034325A1 (fr) * | 2005-09-21 | 2007-03-29 | Pfizer Limited | Derives de carboxamide en tant qu'antagonistes de recepteur muscarinique |
| KR20090107567A (ko) * | 2007-02-09 | 2009-10-13 | 아스텔라스세이야쿠 가부시키가이샤 | 아자 가교환 화합물 |
| UA100983C2 (ru) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
| KR101341693B1 (ko) | 2011-03-16 | 2013-12-16 | 동아에스티 주식회사 | 생약추출물을 함유하는 퇴행성 신경질환의 치료 및 예방을 위한 조성물 |
| KR101341692B1 (ko) | 2011-03-16 | 2013-12-20 | 동아에스티 주식회사 | 복합생약추출물을 함유하는 당뇨병성 말초 신경병증의 치료 및 예방을 위한 조성물 |
| KR101457789B1 (ko) | 2013-02-13 | 2014-11-03 | 동아제약 주식회사 | 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법 |
-
2013
- 2013-07-30 KR KR1020130090175A patent/KR101538846B1/ko active Active
-
2014
- 2014-07-17 CA CA2919624A patent/CA2919624C/fr active Active
- 2014-07-17 ES ES14831249T patent/ES2710389T3/es active Active
- 2014-07-17 TR TR2019/01449T patent/TR201901449T4/tr unknown
- 2014-07-17 JP JP2016531513A patent/JP6109425B2/ja active Active
- 2014-07-17 MX MX2016001200A patent/MX366639B/es active IP Right Grant
- 2014-07-17 PT PT14831249T patent/PT3029026T/pt unknown
- 2014-07-17 SG SG11201600624RA patent/SG11201600624RA/en unknown
- 2014-07-17 MY MYPI2016700263A patent/MY175411A/en unknown
- 2014-07-17 US US14/909,096 patent/US9828339B2/en active Active
- 2014-07-17 WO PCT/KR2014/006483 patent/WO2015016511A1/fr not_active Ceased
- 2014-07-17 AU AU2014297144A patent/AU2014297144B2/en active Active
- 2014-07-17 RU RU2016106977A patent/RU2644234C2/ru active
- 2014-07-17 EP EP14831249.9A patent/EP3029026B1/fr active Active
- 2014-07-17 CN CN201480050982.3A patent/CN105555761B/zh active Active
- 2014-07-17 UA UAA201601871A patent/UA116480C2/uk unknown
-
2016
- 2016-01-28 PH PH12016500197A patent/PH12016500197B1/en unknown
- 2016-01-28 IL IL243830A patent/IL243830B/en active IP Right Grant
- 2016-02-23 ZA ZA2016/01227A patent/ZA201601227B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02968A (fr) | ||
| NZ595307A (en) | Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use | |
| MX2017011951A (es) | Derivados sustituidos de indol 3 novedosos, composiciones farmaceuticas y metodos para uso. | |
| PH12018500533A1 (en) | Pyrazolyl-substituted heteroaryls and their use as medicaments | |
| HRP20241145T1 (hr) | Biciklički aza spojevi kao agonisti muskarinskih receptora | |
| WO2011051490A3 (fr) | Dérivés hétérocycliques | |
| TW201144302A (en) | 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds | |
| WO2011110876A8 (fr) | Nouveaux sels pour fabrication de compositions pharmaceutiques | |
| MY143483A (en) | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders | |
| PE20141167A1 (es) | Piridopirazinas sustituidas como inhibidores novedosos de ptk | |
| MX351305B (es) | Antagonistas del receptor de mineralocorticoides. | |
| HK1207860A1 (en) | 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders | |
| CL2008000119A1 (es) | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. | |
| MX2013008056A (es) | 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
| JOP20130213B1 (ar) | معارضات لمستقبلht3-5 | |
| MX353209B (es) | Antagonistas d2, metodos de sintesis y metodos de uso. | |
| IN2014MN01756A (fr) | ||
| TW201613890A (en) | Pyridine derivatives as muscarinic M1 receptor positive allosteric modulators | |
| MX350862B (es) | Acidos de piperidinil naftilacetico. | |
| WO2010084402A3 (fr) | Composés hétérocycliques en tant qu'inhibiteurs de phosphodiestérase | |
| MX2016008536A (es) | Derivados de fluoro-naftilo. | |
| ATE531692T1 (de) | Als antagonisten am muskarinrezeptor geeignete guanidinhaltige verbindungen | |
| PH12016500197A1 (en) | Novel biphenyl derivative and method for preparing same | |
| WO2014014794A3 (fr) | Antagonistes des récepteurs aux minéralocorticoïdes | |
| SI2532651T1 (sl) | Postopek sinteze in kristalinična oblika 4-(3-(cis-heksahidrociklopenta(c)pirol-2(1H)-il)propoksi) benzamid hidroklorida ter njegova prosta baza, pa tudi farmacevtski sestavki, ki ju vsebujejo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |